JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/70/0.1/21.06.24

JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/70/0.1/21.06.24 Stock

Warrant

DE000JQ506G5

Market Closed - Bid/Ask 05:22:53 2024-06-11 EDT			After market 14:39:48
0.002 ^EUR	0.00%		0.025	+1,150.00%

Current month	+100.00%
3 months	-80.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart JP MORGAN/CALL/BRISTOL-MYERS SQUIBB/70/0.1/21.06.24

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024	07:00am	BU
Bristol Myers: ex-CEO of Agilent joins Board of Directors	06-19	CF
Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors	06-18	BU
Bristol Myers Squibb Appoints Michael R. McMullen as Independent Director and Member of the Audit Committee, Effective July 1, 2024	06-18	CI

More news

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	J.P. Morgan
WKN	JQ506G
ISIN	DE000JQ506G5
Date issued	2022-09-23
Strike	70 $
Maturity	2024-06-21 (1 Days)
Parity	10 : 1
Emission price	1.04 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.73 €
Lowest since issue	0.001 €
Spread	0.049 €
Spread %	98.00%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company